{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:59:20Z","timestamp":1791932360154,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jaut.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T23:01:08Z","timestamp":1411686068000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"special_numbering":"C","title":["Clinical features and pathobiology of Ebolavirus infection"],"prefix":"10.1016","volume":"55","author":[{"given":"Aftab A.","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2014.09.001_bib1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of Zaire Ebola virus disease in guinea \u2013 preliminary report","author":"Baize","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2014.09.001_bib2","first-page":"6","article-title":"Phylogenetic analysis of guinea 2014 EBOV Ebolavirus outbreak","author":"Dudas","year":"2014","journal-title":"PLoS Curr"},{"key":"10.1016\/j.jaut.2014.09.001_bib3","unstructured":"Gire SK, Goba A, Andersen KG, Sealfon RSG, Park DJ, Kanneh L, et\u00a0al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science."},{"key":"10.1016\/j.jaut.2014.09.001_bib4","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1099\/vir.0.067199-0","article-title":"The 2014 Ebola virus disease outbreak in West Africa","author":"Gatherer","year":"2014","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib5","doi-asserted-by":"crossref","first-page":"e96360","DOI":"10.1371\/journal.pone.0096360","article-title":"Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus","volume":"9","author":"Becquart","year":"2014","journal-title":"PloS One"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.jaut.2014.09.001_bib6","doi-asserted-by":"crossref","first-page":"S768","DOI":"10.1093\/infdis\/jir344","article-title":"Risk factors for Zaire ebolavirus \u2013 specific IgG in rural Gabonese populations","volume":"204","author":"Nkoghe","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaut.2014.09.001_bib7","first-page":"1229","article-title":"Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA","volume":"159","author":"Kuhn","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib8","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/JVI.03118-12","article-title":"Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences","volume":"87","author":"Carroll","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib9","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1128\/JVI.01272-14","article-title":"A\u00a0novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity","volume":"88","author":"Watt","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib10","first-page":"300","article-title":"Membrane binding and bending in Ebola VP40 assembly and egress","volume":"5","author":"Stahelin","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaut.2014.09.001_bib11","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJMp1409494","article-title":"Ebola \u2013 underscoring the global disparities in health care resources","volume":"371","author":"Fauci","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jaut.2014.09.001_bib12","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/514319","article-title":"A\u00a0novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit","volume":"179","author":"Zaki","year":"1999","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaut.2014.09.001_bib13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/CVI.13.4.444-451.2006","article-title":"Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins","volume":"13","author":"Saijo","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jaut.2014.09.001_bib14","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.3390\/v4123511","article-title":"Standardization of the filovirus plaque assay for use in preclinical studies","volume":"4","author":"Shurtleff","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.jaut.2014.09.001_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jviromet.2013.05.015","article-title":"Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity","volume":"193","author":"Smither","year":"2013","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.jaut.2014.09.001_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/1744666X.2014.908705","article-title":"Characterization of host immune responses in Ebola virus infections","volume":"10","author":"Wong","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaut.2014.09.001_bib17","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1128\/JVI.02695-12","article-title":"Ebola virus exploits a monocyte differentiation program to promote its entry","volume":"87","author":"Martinez","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib18","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1073\/pnas.94.26.14764","article-title":"A\u00a0system for functional analysis of Ebola virus glycoprotein","volume":"94","author":"Takada","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.09.001_bib19","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/JVI.72.4.3155-3160.1998","article-title":"Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines","volume":"72","author":"Wool-Lewis","year":"1998","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2006.06.041","article-title":"Characterization of Marburg virus glycoprotein in viral entry","volume":"358","author":"Manicassamy","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2014.09.001_bib21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/78654","article-title":"Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury","volume":"6","author":"Yang","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.09.001_bib22","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1128\/JVI.02021-09","article-title":"Different potential of C-type lectin-mediated entry between Marburg virus strains","volume":"84","author":"Matsuno","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib23","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fmicb.2012.00034","article-title":"Filovirus tropism: cellular molecules for viral entry","volume":"3","author":"Takada","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaut.2014.09.001_bib25","doi-asserted-by":"crossref","first-page":"e1003258","DOI":"10.1371\/journal.ppat.1003258","article-title":"The secret life of viral entry glycoproteins: moonlighting in immune evasion","volume":"9","author":"Cook","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaut.2014.09.001_bib26","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/JVI.78.2.958-967.2004","article-title":"Persistent infection with Ebola virus under conditions of partial immunity","volume":"78","author":"Gupta","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib27","doi-asserted-by":"crossref","first-page":"e89735","DOI":"10.1371\/journal.pone.0089735","article-title":"Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation","volume":"9","author":"Martins","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2014.09.001_bib28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2013.03.028","article-title":"Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha\/beta receptor knock-out mouse","volume":"452\u2013453","author":"O'Brien","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2014.09.001_bib29","doi-asserted-by":"crossref","first-page":"158ra46","DOI":"10.1126\/scitranslmed.3004582","article-title":"Immune parameters correlate with protection against Ebola virus infection in rodents and nonhuman primates","volume":"4","author":"Wong","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaut.2014.09.001_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm0198-037","article-title":"Immunization for Ebola virus infection","volume":"4","author":"Xu","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.09.001_bib31","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1073\/pnas.050588297","article-title":"In\u00a0vivo natural killer cell activities revealed by natural killer cell-deficient mice","volume":"97","author":"Kim","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.09.001_bib32","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1128\/JVI.79.22.14189-14196.2005","article-title":"Protective cytotoxic T-cell responses induced by Venezuelan equine encephalitis virus replicons expressing Ebola virus proteins","volume":"79","author":"Olinger","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib33","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"Sullivan","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.09.001_bib34","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.09.001_bib35","doi-asserted-by":"crossref","first-page":"e5308","DOI":"10.1371\/journal.pone.0005308","article-title":"Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine","volume":"4","author":"Richardson","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2014.09.001_bib36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.09.001_bib37","doi-asserted-by":"crossref","first-page":"e9126","DOI":"10.1371\/journal.pone.0009126","article-title":"High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon","volume":"5","author":"Becquart","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2014.09.001_bib38","doi-asserted-by":"crossref","first-page":"e3061","DOI":"10.1371\/journal.pntd.0003061","article-title":"Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus","volume":"8","author":"Garamszegi","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaut.2014.09.001_bib39","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1128\/JVI.01410-14","article-title":"Ebola virus modulates transforming growth factor beta signaling and cellular markers of mesenchyme-like transition in hepatocytes","volume":"88","author":"Kindrachuk","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.jaut.2014.09.001_bib40","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1086\/520598","article-title":"Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever","volume":"196","author":"Hensley","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaut.2014.09.001_bib41","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(03)15012-X","article-title":"Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: a study in rhesus monkeys","volume":"362","author":"Geisbert","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jaut.2014.09.001_bib42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40259-013-0046-1","article-title":"Emerging targets and novel approaches to Ebola virus prophylaxis and treatment","volume":"27","author":"Choi","year":"2013","journal-title":"BioDrugs"},{"key":"10.1016\/j.jaut.2014.09.001_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.09.001_bib44","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1128\/JVI.03050-13","article-title":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay","volume":"88","author":"Elshabrawy","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.jaut.2014.09.001_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/med.21281","article-title":"A\u00a0cutting-edge view on the current state of antiviral drug development","author":"De Clercq","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jaut.2014.09.001_bib47","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1021\/bi400704d","article-title":"Development of RNA aptamers targeting Ebola virus VP35","volume":"52","author":"Binning","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaut.2014.09.001_bib48","doi-asserted-by":"crossref","first-page":"e2600","DOI":"10.1371\/journal.pntd.0002600","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus","volume":"7","author":"Mire","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaut.2014.09.001_bib49","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1517\/14712598.2012.685152","article-title":"Current Ebola vaccines","volume":"12","author":"Hoenen","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jaut.2014.09.001_bib50","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.76.18.9176-9185.2002","article-title":"Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells","volume":"76","author":"Rao","year":"2002","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib51","doi-asserted-by":"crossref","first-page":"e1000904","DOI":"10.1371\/journal.ppat.1000904","article-title":"Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus species","volume":"6","author":"Hensley","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaut.2014.09.001_bib52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/CVI.00467-09","article-title":"Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector","volume":"17","author":"Pratt","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jaut.2014.09.001_bib53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.virusres.2014.06.001","article-title":"A\u00a0highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody","volume":"189","author":"Wang","year":"2014","journal-title":"Virus Res"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.jaut.2014.09.001_bib54","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaut.2014.09.001_bib55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2008.09.020","article-title":"Protection against lethal challenge by Ebola virus-like particles produced in insect cells","volume":"383","author":"Sun","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2014.09.001_bib56","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/JVI.00074-09","article-title":"Replication-deficient ebolavirus as a vaccine candidate","volume":"83","author":"Halfmann","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib57","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.09.001_bib58","doi-asserted-by":"crossref","first-page":"e1000225","DOI":"10.1371\/journal.ppat.1000225","article-title":"Vesicular stomatitis virus-based Ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates","volume":"4","author":"Geisbert","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaut.2014.09.001_bib59","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaut.2014.09.001_bib60","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00105-07","article-title":"Successful topical respiratory tract immunization of primates against Ebola virus","volume":"81","author":"Bukreyev","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib61","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.00558-11","article-title":"Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses","volume":"85","author":"Blaney","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.09.001_bib62","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.09.001_bib63","doi-asserted-by":"crossref","first-page":"138ra81","DOI":"10.1126\/scitranslmed.3003876","article-title":"Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"Qiu","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaut.2014.09.001_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","author":"Qiu","year":"2014","journal-title":"Nature"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114001309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114001309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:10:24Z","timestamp":1760256624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114001309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":64,"alternative-id":["S0896841114001309"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2014.09.001","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and pathobiology of Ebolavirus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}